1991
DOI: 10.1016/0009-2797(91)90106-h
|View full text |Cite
|
Sign up to set email alerts
|

Evidence of an adriamycin binding site in the secretory granules of the mast cell

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

1993
1993
1997
1997

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…Adriamycin is another candidate for bind ing to mast cell granules: indeed, the antineoplastic drug Adriamycin is avidly taken up by mast cells only after these cells are induced to exocytose [17,18]. It is known that Adriamycin easily forms an ionic complex with hepa rin [19][20][21], with one molecule of heparin binding 16 molecules of Adriamycin [19], and hence it is conceivable that the drug binds to the heparin proteoglycan of mast cell gran ules.…”
Section: Discussionmentioning
confidence: 99%
“…Adriamycin is another candidate for bind ing to mast cell granules: indeed, the antineoplastic drug Adriamycin is avidly taken up by mast cells only after these cells are induced to exocytose [17,18]. It is known that Adriamycin easily forms an ionic complex with hepa rin [19][20][21], with one molecule of heparin binding 16 molecules of Adriamycin [19], and hence it is conceivable that the drug binds to the heparin proteoglycan of mast cell gran ules.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, in mast cells adriamycin induces a significant, noncytotoxic histamine release that seems to play a role in adriamycin-induced cardiotoxicity (Klugmann et al 1986). The consequence of the exocytotic process is the externalization of a granular binding site for which adriamycin possesses an extraordinary affinity (Decorti et al 1991).…”
mentioning
confidence: 99%
“…lb) cells, without any inhibitory activity on adriamycin-induced histamine release (data not shown). Adriamycin exhibits an extraordinary affinity for mast cells; indeed, following exocytosis, a granular binding site is externalized, the nature of which is at present unclear (Decorti et al 1991). Specific binding of adriamycin to membrane lipids such as cardiolipin, phosphatidylserine and phosphatidic acid (Goormaghtigh et al 1987) has been demonstrated and it seems of interest that, following stimulation to secretion, in many secretory cells, including mast cell (Kennedy et al 1979) there is an extensive net conversion of phosphatidyl inositol to phosphatidic acid.…”
mentioning
confidence: 99%